This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Illumina welcomes lifting of China's export ban, pledges engagement for lasting solution

( November 6, 2025, 08:25 GMT | Official Statement) -- MLex Summary: US biotechnology company Illumina welcomed the Chinese Ministry of Commerce’s decision to lift its March 4 ban on exports of Illumina’s gene-sequencing instruments to China, describing it as a positive development and pledging continued engagement to work toward a long-term solution. The ministry’s move, announced Wednesday as part of broader adjustments to its Unreliable Entity List measures targeting US businesses, reverses restrictions imposed earlier this year.The statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections